Anticoagulation in the Elderly
Specialized approach to blood thinning therapy in elderly patients, balancing stroke prevention against bleeding risk while considering cognitive and functional status.
Full Definition
Anticoagulation in the elderly requires careful consideration of multiple factors including increased bleeding risk, drug interactions, cognitive impairment affecting medication adherence, and altered pharmacokinetics. Elderly patients with atrial fibrillation typically have higher CHA2DS2-VASc scores warranting anticoagulation, but also have increased HAS-BLED scores indicating elevated bleeding risk. Direct oral anticoagulants (DOACs) are often preferred over warfarin due to more predictable dosing and fewer drug interactions, though dose adjustments may be necessary based on renal function and body weight. Management decisions must incorporate patient preferences, goals of care, and quality of life considerations. Regular monitoring for both efficacy and safety is essential, with particular attention to falls risk and cognitive changes that might affect medication safety.
Usage
Usage note: Emphasize the multifactorial decision-making process and individualized approach.
In Context
- "Anticoagulation in the elderly required careful risk-benefit analysis given her history of falls and cognitive impairment." — Treatment planning note
- "The geriatric cardiology team specialized in optimizing anticoagulation in the elderly population." — Clinical service description